Literature DB >> 20072881

Mannosylated liposomes for targeted vaccines delivery.

Suresh Prasad Vyas1, Amit K Goyal, Kapil Khatri.   

Abstract

Mannosylated liposomes appear to be a promising and potential carrier system for delivery of proteins, peptides, or nucleic acids. The present chapter describes novel mannosylated liposomes, which increase the intracellular targeting of immunogen to dendritic cells and macrophages possessing the specific receptors. The liposomes used in the present investigation were prepared by hand-shaken method and characterized for size, shape, surface charge, encapsulation efficiency, ligand binding, and specificity and uptake studies. The immune-stimulating activity of the liposomes was studied by measuring antigen-specific antibody titer following subcutaneous administration of different liposomal formulations in BALB/c mice. It was found that O-palmitoyl mannan (OPM)-coated liposomes showed better uptake efficiency. In vivo studies revealed that the OPM-coated liposomes exhibited significant higher serum antibody response and stronger TH1/TH2-based cellular responses. In conclusion, novel vesicular constructs are useful nanosized carriers having superior surface characteristics--for active interaction with the antigen-presenting cells and subsequent processing and presentation of antigen.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20072881     DOI: 10.1007/978-1-60327-360-2_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Authors:  Charles H Jones; Anders P Hakansson; Blaine A Pfeifer
Journal:  J Mater Chem B       Date:  2014-09-12       Impact factor: 6.331

Review 2.  Innate immune cells in breast cancer--from villains to heroes?

Authors:  Tim Kees; Mikala Egeblad
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-07-26       Impact factor: 2.673

3.  Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles.

Authors:  Haibin Huang; Gary R Ostroff; Chrono K Lee; Charles A Specht; Stuart M Levitz
Journal:  MBio       Date:  2010-07-20       Impact factor: 7.867

4.  DNA vaccination for prostate cancer: key concepts and considerations.

Authors:  Grace Cole; Joanne McCaffrey; Ahlam A Ali; Helen O McCarthy
Journal:  Cancer Nanotechnol       Date:  2015-07-02

Review 5.  Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines.

Authors:  Aloysious Ssemaganda; Ashwini Kumar Giddam; Mehfuz Zaman; Mariusz Skwarczynski; Istvan Toth; Danielle I Stanisic; Michael F Good
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

Review 6.  Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines.

Authors:  Kyle K L Phua
Journal:  J Immunol Res       Date:  2015-12-24       Impact factor: 4.818

7.  Therapeutic Efficacy of Delta-Like Ligand 4 Gene Vaccine Overexpression on Liver Cancer in Mice.

Authors:  Yi Yu; Yang Zhao; Guangming Zhou; Xiang Wang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.